Replacing the

Syringe with a Pill.

i2o Therapeutics has developed a disruptive ionic liquid technology, enabling the oral delivery of peptides, proteins, and other injection-based drugs.

About Us

i2o Therapeutics is a biotech company developing safe and effective oral formulations of therapies traditionally limited to injections. 


Our Technology

Using an innovative ionic liquid technology, this platform leverages the benefits of protecting the drug cargo while also transiently enhancing permeation across the epithelial lining when administered orally. 


i2o is focused on creating the next generation of oral peptide and protein-based therapies.


Revolutionary Oral Delivery Platform

High Bioavailability

Injection-Free Delivery

Low Cost of Goods

Readily Scalable

Superior Drug Loading

Compatible with Diverse Drug Types

Founding Team


In the News



Want to join the i2o team?
Get in touch with us!
i2o Therapeutics, Inc.
127 Western Ave
Allston, MA 02134